Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients

BACKGROUND: Targeted axillary dissection (TAD) combines sentinel node biopsy (SNB) with the removal of the previously marked metastatic node. TAD is a promising concept for axillary restaging in node-positive breast cancer patients with pathological complete response (pCR) to neoadjuvant therapy (NA...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, C. S., Peleteiro, B., Pinto, C. A., Osório, F., Costa, S., Magalhães, A., Mora, H., Amaral, J., Gonçalves, D., Fougo, J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933233/
https://www.ncbi.nlm.nih.gov/pubmed/35304711
http://dx.doi.org/10.1007/s12282-022-01349-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933233/
https://www.ncbi.nlm.nih.gov/pubmed/35304711
http://dx.doi.org/10.1007/s12282-022-01349-x

Ejemplares similares